These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
311 related articles for article (PubMed ID: 16395283)
1. HIV-TAT protein upregulates expression of multidrug resistance protein 1 in the blood-brain barrier. Hayashi K; Pu H; Andras IE; Eum SY; Yamauchi A; Hennig B; Toborek M J Cereb Blood Flow Metab; 2006 Aug; 26(8):1052-65. PubMed ID: 16395283 [TBL] [Abstract][Full Text] [Related]
2. HIV-Tat protein induces P-glycoprotein expression in brain microvascular endothelial cells. Hayashi K; Pu H; Tian J; Andras IE; Lee YW; Hennig B; Toborek M J Neurochem; 2005 Jun; 93(5):1231-41. PubMed ID: 15934943 [TBL] [Abstract][Full Text] [Related]
3. HIV-1 Tat protein alters tight junction protein expression and distribution in cultured brain endothelial cells. András IE; Pu H; Deli MA; Nath A; Hennig B; Toborek M J Neurosci Res; 2003 Oct; 74(2):255-65. PubMed ID: 14515355 [TBL] [Abstract][Full Text] [Related]
4. Signaling mechanisms of HIV-1 Tat-induced alterations of claudin-5 expression in brain endothelial cells. András IE; Pu H; Tian J; Deli MA; Nath A; Hennig B; Toborek M J Cereb Blood Flow Metab; 2005 Sep; 25(9):1159-70. PubMed ID: 15815581 [TBL] [Abstract][Full Text] [Related]
5. Permeability of the blood-brain barrier to HIV-1 Tat. Banks WA; Robinson SM; Nath A Exp Neurol; 2005 May; 193(1):218-27. PubMed ID: 15817280 [TBL] [Abstract][Full Text] [Related]
6. Synergistic increases in intracellular Ca2+, and the release of MCP-1, RANTES, and IL-6 by astrocytes treated with opiates and HIV-1 Tat. El-Hage N; Gurwell JA; Singh IN; Knapp PE; Nath A; Hauser KF Glia; 2005 Apr; 50(2):91-106. PubMed ID: 15630704 [TBL] [Abstract][Full Text] [Related]
7. Effects of HIV-1 Tat and Methamphetamine on Blood-Brain Barrier Integrity and Function Patel S; Leibrand CR; Palasuberniam P; Couraud PO; Weksler B; Jahr FM; McClay JL; Hauser KF; McRae M Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28893794 [TBL] [Abstract][Full Text] [Related]
8. Specific increase in MDR1 mediated drug-efflux in human brain endothelial cells following co-exposure to HIV-1 and saquinavir. Roy U; Bulot C; Honer zu Bentrup K; Mondal D PLoS One; 2013; 8(10):e75374. PubMed ID: 24098380 [TBL] [Abstract][Full Text] [Related]
9. Differential Mechanisms of Inflammation and Endothelial Dysfunction by HIV-1 Subtype-B and Recombinant CRF02_AG Tat Proteins on Human Brain Microvascular Endothelial Cells: Implications for Viral Neuropathogenesis. Bhargavan B; Kanmogne GD Mol Neurobiol; 2018 Feb; 55(2):1352-1363. PubMed ID: 28127697 [TBL] [Abstract][Full Text] [Related]
10. Mechanisms of leukocyte trafficking into the CNS. Wu DT; Woodman SE; Weiss JM; McManus CM; D'Aversa TG; Hesselgesser J; Major EO; Nath A; Berman JW J Neurovirol; 2000 May; 6 Suppl 1():S82-5. PubMed ID: 10871769 [TBL] [Abstract][Full Text] [Related]
11. HIV-1 viral proteins gp120 and Tat induce oxidative stress in brain endothelial cells. Price TO; Ercal N; Nakaoke R; Banks WA Brain Res; 2005 May; 1045(1-2):57-63. PubMed ID: 15910762 [TBL] [Abstract][Full Text] [Related]
12. Interactive role of human immunodeficiency virus type 1 (HIV-1) clade-specific Tat protein and cocaine in blood-brain barrier dysfunction: implications for HIV-1-associated neurocognitive disorder. Gandhi N; Saiyed ZM; Napuri J; Samikkannu T; Reddy PV; Agudelo M; Khatavkar P; Saxena SK; Nair MP J Neurovirol; 2010 Jul; 16(4):294-305. PubMed ID: 20624003 [TBL] [Abstract][Full Text] [Related]
13. HIV-1 Tat and opioids act independently to limit antiretroviral brain concentrations and reduce blood-brain barrier integrity. Leibrand CR; Paris JJ; Jones AM; Masuda QN; Halquist MS; Kim WK; Knapp PE; Kashuba ADM; Hauser KF; McRae M J Neurovirol; 2019 Aug; 25(4):560-577. PubMed ID: 31102185 [TBL] [Abstract][Full Text] [Related]
14. Astrocyte activation and dysfunction and neuron death by HIV-1 Tat expression in astrocytes. Zhou BY; Liu Y; Kim Bo; Xiao Y; He JJ Mol Cell Neurosci; 2004 Nov; 27(3):296-305. PubMed ID: 15519244 [TBL] [Abstract][Full Text] [Related]
15. HIV-1 Tat protein increases the permeability of brain endothelial cells by both inhibiting occludin expression and cleaving occludin via matrix metalloproteinase-9. Xu R; Feng X; Xie X; Zhang J; Wu D; Xu L Brain Res; 2012 Feb; 1436():13-9. PubMed ID: 22197032 [TBL] [Abstract][Full Text] [Related]
16. Human immunodeficiency virus type 1 TAT protein induces adhesion molecule expression in astrocytes. Woodman SE; Benveniste EN; Nath A; Berman JW J Neurovirol; 1999 Dec; 5(6):678-84. PubMed ID: 10602408 [TBL] [Abstract][Full Text] [Related]
17. Induction of C chemokine XCL1 (lymphotactin/single C motif-1 alpha/activation-induced, T cell-derived and chemokine-related cytokine) expression by HIV-1 Tat protein. Kim BO; Liu Y; Zhou BY; He JJ J Immunol; 2004 Feb; 172(3):1888-95. PubMed ID: 14734774 [TBL] [Abstract][Full Text] [Related]
18. Differential effects of Tat proteins derived from HIV-1 subtypes B and recombinant CRF02_AG on human brain microvascular endothelial cells: implications for blood-brain barrier dysfunction. Woollard SM; Bhargavan B; Yu F; Kanmogne GD J Cereb Blood Flow Metab; 2014 Jun; 34(6):1047-59. PubMed ID: 24667918 [TBL] [Abstract][Full Text] [Related]
19. Tat 101-mediated enhancement of brain pericyte migration involves platelet-derived growth factor subunit B homodimer: implications for human immunodeficiency virus-associated neurocognitive disorders. Niu F; Yao H; Zhang W; Sutliff RL; Buch S J Neurosci; 2014 Aug; 34(35):11812-25. PubMed ID: 25164676 [TBL] [Abstract][Full Text] [Related]
20. Intracellular human immunodeficiency virus Tat expression in astrocytes promotes astrocyte survival but induces potent neurotoxicity at distant sites via axonal transport. Chauhan A; Turchan J; Pocernich C; Bruce-Keller A; Roth S; Butterfield DA; Major EO; Nath A J Biol Chem; 2003 Apr; 278(15):13512-9. PubMed ID: 12551932 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]